Susceptibility Pattern of Bacille Calmette-Guerin Strains Against Pyrazinamide and Other Major Anti-Mycobacterial Drugs
Pyrazinamide
Ethionamide
Antimycobacterial
DOI:
10.5812/pedinfect.17814
Publication Date:
2014-07-26T09:49:52Z
AUTHORS (6)
ABSTRACT
Background: BCG (Bacille Calmette-Guerin) vaccine is an attenuated live administered to prevent Tuberculosis. Disseminated infection due a rare life threatening complication of this vaccine, especially in immunocompromised patients. Objectives: The current study evaluated the sensitivity pattern strain supplied by Institute de Pasteur, Iran against anti-mycobacterial drugs used treat disseminated caused vaccine. Patients and Materials: Bacille Calmette-Guerin ATCC 1173 P was purchased from Pasteur Tehran three samples Mycobacterium bovis isolated subaxillary adenitis patients were tested for susceptibility major MODS (microscopic observation drug sensitivity) method. Results: All resistant most separately except concentrations isoniazid 1 µg/mL, ethambutol 3 ciprofloxacin 4 µg/mL clarithromycin 2 µg/mL. Addition pyrazinamide (PZA) 25 did not change any , but increasing PZA concentration 50 µg/ml combining it with ethionamide 0.2 streptomycin rifampin 0.5 or made strains susceptible. Conclusions: findings revealed that resistance resolved other agents.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (18)
CITATIONS (4)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....